Spire Wealth Management

Position in OGN — Organon & Co.

CIK 1858740 MCLEAN, VA

Position in OGN

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,678

+$1,163 QoQ

Shares Held

124

+44.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#432

of 626 holders

Holding Since

Jun 2022

17 quarters on record

Healthcare · as of Jun 30, 2026

Spire Wealth Management holds $51,426,589 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	27,938	$33,509,677
2	NVS	Novartis AG	35,965	$5,636,434
3	ABBV	AbbVie Inc.	13,113	$3,299,755
4	JNJ	Johnson & Johnson	12,264	$3,114,688
5	MRK	Merck & Co., Inc.	19,212	$2,468,742
6	AMGN	Amgen Inc	4,384	$1,587,534
7	GILD	Gilead Sciences, Inc.	4,696	$593,292
8	PFE	Pfizer Inc	18,451	$444,300

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,678	124	+44.2%	Shares	Sole	2026-07-15
2026-03-31	$515	86	-96.4%	Shares	Sole	2026-04-22
2025-12-31	$17,107	2,386	-69.3%	Shares	Sole	2026-01-14
2025-09-30	$82,940	7,766	+0.3%	Shares	Sole	2025-10-23
2025-06-30	$74,932	7,741	+37.6%	Shares	Sole	2025-08-04
2025-03-31	$83,741	5,624	-6.1%	Shares	Sole	2025-04-23
2024-12-31	$89,340	5,988	+39.6%	Shares	Sole	2025-01-24
2024-09-30	$82,029	4,288	-0.6%	Shares	Sole	2024-10-15
2024-06-30	$89,279	4,313	-28.4%	Shares	Sole	2024-07-31
2024-03-31	$113,270	6,025	-4.1%	Shares	Sole	2024-04-24
2023-12-31	$90,600	6,283	+60.0%	Shares	Sole	2024-02-06
2023-09-30	$68,190	3,928	-28.4%	Shares	Sole	2023-11-08
2023-06-30	$114,163	5,486	+1.8%	Shares	Sole	2023-08-09
2023-03-31	$126,725	5,388	+39.4%	Shares	Sole	2023-05-09
2022-12-31	$107,949	3,865	+86.3%	Shares	Sole	2023-02-03
2022-09-30	$48,555	2,075	-80.8%	Shares	Sole	2022-11-07
2022-06-30	$364,871	10,811	—	Shares	Sole	2022-07-22
No filing history on record for this holder in this stock.